MedTrace Logo

Study on Genetically Affected Sporadic Thoracic Aortic Aneurysm and Dissection

NCT02852603 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2021-04-13

No results posted yet for this study

Summary

Mortality of thoracic aortic aneurysm and dissection (TAAD) remains high because of the huge blood lost from the aorta. Questions about the potentially genetic effects on sporadic TAAD are raised by researchers to explore the possible mechanisms leading to sporadic TAAD and to establish new clinical approaches to prevent TAAD-caused adverse clinical outcomes. This study is intended to collect the gene information in sporadic TAAD patients and to explore the relationship between genetic variation and the incidence of sporadic TAAD for further study.

Conditions

  • Dissection of Aorta, Thoracic
  • Aneurysm of Aorta, Thoracic

Sponsors & Collaborators

  • Fu Wai Hospital, Beijing, China

    collaborator OTHER

  • Wuhan Asia Heart Hospital

    lead OTHER

Principal Investigators

  • Xuan Zheng, MD, PhD · Wuhan Asia Heart Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2019-01-31
Completion
2020-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02852603 on ClinicalTrials.gov